Free Trial
TSE:HBP

Helix BioPharma (HBP) Stock Price, News & Analysis

C$0.23
0.00 (0.00%)
(As of 07/15/2024 ET)
Today's Range
C$0.23
C$0.23
50-Day Range
C$0.21
C$0.27
52-Week Range
C$0.15
C$0.27
Volume
4,000 shs
Average Volume
13,942 shs
Market Capitalization
C$52.77 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
HBP stock logo

About Helix BioPharma Stock (TSE:HBP)

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

HBP Stock Price History

HBP Stock News Headlines

Helix Biopharma: Fiscal Q2 Earnings Snapshot
[36,483% Gain] Your 90 Day Gameplan
Ever caught yourself thinking, "there's got to be an easier way to crack this crypto code"? Well, you’re right. And today, I’m unveiling a game-changer.
Helix Biopharma GAAP EPS of -C$0.01
[36,483% Gain] Your 90 Day Gameplan
Ever caught yourself thinking, "there's got to be an easier way to crack this crypto code"? Well, you’re right. And today, I’m unveiling a game-changer.
See More Headlines
Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
7/17/2024
Next Earnings (Estimated)
10/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Net Income
C$-5,940,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$52.77 million
Optionable
Not Optionable
Beta
-0.78
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Jacek Antas
    Chairman & CEO
  • Mr. Praveen Kumar Varshney F.C.A. (Age 58)
    FCA, FCPA, LLB, CFO & Corporate Secretary
  • Dr. Gabrielle M. Siegers M.A.
    Ph.D., Head of R&D
  • Dr. Srikanth Sola
    Chief Strategy Officer
  • Dr. Christof Boehler
    Chief Business Development Officer

HBP Stock Analysis - Frequently Asked Questions

How have HBP shares performed this year?

Helix BioPharma's stock was trading at C$0.21 on January 1st, 2024. Since then, HBP stock has increased by 9.5% and is now trading at C$0.23.
View the best growth stocks for 2024 here
.

How do I buy shares of Helix BioPharma?

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Helix BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE) and American Airlines Group (AAL).

This page (TSE:HBP) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners